Neuro-oncologist joins Penn’s mission to fight brain cancer Richard Phillips, a Presidential Assistant Professor of Neurology and member of the Penn Epigenetics Institute, hopes to bring glioma research out of the “basement.”
a Presidential Assistant Professor of Neurology and member of the Penn Epigenetics Institute, is fairly new to the Penn Medicine family and the city of Philadelphia. Originally from England, Phillips made his way to the United States after graduating from medical school at King’s College London. He completed his internship at Massachusetts General Hospital, a residency in Neurology at Harvard/MGH Brigham in Boston, and a fellowship in Neuro-Oncology at Memorial Sloan Kettering Cancer Center where he stayed on as faculty. But in November 2020, he made the move to Penn’s Perelman School of Medicine.
Discovery of a new genetic cause of hearing loss illuminates how inner ear works A Penn Medicine study shows a link between mutations of the GAS2 gene and the ability to amplify incoming sound, providing a research target for future gene therapy.
A gene called
GAS2 plays a key role in normal hearing, and its absence causes severe hearing loss, according to a study led by researchers in Penn’s Perelman School of Medicine.
Developmental Cell, discovered that the protein encoded by
GAS2 is crucial for maintaining the structural stiffness of support cells in the inner ear that normally help amplify incoming sound waves. They showed that inner ear support cells lacking functional
Curbing mass evictions during pandemic have played key role in preventing SARS-CoV-2 transmission news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.
Share This
The FINANCIAL Many long for a return to a post-pandemic “normal,” which, for some, may entail concerts, travel, and large gatherings. But how to keep safe amid these potential public health risks?
According to University of Pennsylvania, one possibility, according to a new study, is dogs. A proof-of-concept investigation published today in the journal PLOS ONE suggests that specially trained detection dogs can sniff out COVID-19-positive samples with 96% accuracy.
“This is not a simple thing we’re asking the dogs to do,” says Cynthia Otto, senior author on the work and director of the University of Pennsylvania School of Veterinary Medicine Working Dog Center. “Dogs have to be specific about detecting the odor of the infection, but they also have to generalize across the background odors of different people: men and women, adults and children, people of different ethnicities and geographies.”
The Richard W. Vague Professor in Immunotherapy in the department of Pathology and Laboratory Medicine in the Perelman School of Medicine and director of the Center for Cellular Immunotherapies at Penn’s Abramson Cancer Center received the award for his work in developing chimeric antigen receptor (CAR) T cell therapy.